Private Equity 8 Hours

Last updated: September 18, 2026, 2:01 PM ET

UK Sovereign AI Fund Backs Drug Discovery

The UK Sovereign AI Fund is in advanced talks to anchor a £500m raise for a drug discovery startup, in what would rank among the largest AI-focused life sciences rounds in Europe this year. The deal underscores sovereign wealth's growing appetite for computational biology assets.

Family Offices Flock to AI

Family offices are piling into AI at a pace that has some allocators questioning whether the shift is structural or cyclical. The surge in private wealth capital mirrors institutional demand, though concentration risk remains a concern.

PE Bets on Medical Textiles

Montagu, Kohlberg, and Arlington are backing medical textiles as demand for wound dressings climbs. The same consortium is circling fertility treatment assets, with Amulet Capital's track record at US Fertility cited as a template. Across the sector, eight medical textile deals have closed, with Montagu, Kohlberg, Sterling, and Arlington among the most active buyers.

Amulet Promotes Brinkley

Amulet Capital has elevated Sam Brinkley to partner. Brinkley joined the healthcare-focused firm in 2020 as a vice president before rising to principal, and his promotion signals Amulet's intent to deepen its fertility and provider-services franchise.

Alpine Targets UK Facilities

San Francisco-based Alpine Investors has launched a UK platform, Eight Group Service Partners, betting that the fragmented British facilities-services market can replicate US technical services consolidation. It marks Alpine's first UK platform investment since September.

Mutares Exits Cimos

Mutares has sold Cimos in a management buyout backed by Vero Automotive. Cimos, a producer of aluminum and iron castings and machined components, changes hands as European automotive suppliers face margin pressure from EV transition costs.

US VC Conversations Shift

The biggest debates in US venture capital now center on AI capex durability, exit routes, and LP liquidity. Meanwhile, an analysis of 25,000 applications finds the most-fundable seed startups prioritize a clear go-to-market strategy and test distribution early, rather than chasing product breadth.

Fusion and AI Safety on Stage

Inertia co-founder and CEO Jeff Lawson will discuss fusion on the Smart Systems Stage at Tech Crunch Disrupt 2026, as the startup pursues a commercial path for fusion energy. Separately, safety expert Denis Shilov warns that AI development has become a modern nuclear arms race, urging slower deployment. Organizers note the final 24 hours to book exhibit tables, with the deadline set for September 18.